These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30571121)

  • 1. α-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease.
    Moreno-Cinos C; Sassetti E; Salado IG; Witt G; Benramdane S; Reinhardt L; Cruz CD; Joossens J; Van der Veken P; Brötz-Oesterhelt H; Tammela P; Winterhalter M; Gribbon P; Windshügel B; Augustyns K
    J Med Chem; 2019 Jan; 62(2):774-797. PubMed ID: 30571121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Characterization of Approved Drugs and Drug-Like Compounds as Covalent
    Sassetti E; Durante Cruz C; Tammela P; Winterhalter M; Augustyns K; Gribbon P; Windshügel B
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for Deoligomerization.
    Hackl MW; Lakemeyer M; Dahmen M; Glaser M; Pahl A; Lorenz-Baath K; Menzel T; Sievers S; Böttcher T; Antes I; Waldmann H; Sieber SA
    J Am Chem Soc; 2015 Jul; 137(26):8475-83. PubMed ID: 26083639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers
    Ju Y; He L; Zhou Y; Yang T; Sun K; Song R; Yang Y; Li C; Sang Z; Bao R; Luo Y
    J Med Chem; 2020 Mar; 63(6):3104-3119. PubMed ID: 32031798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activators of cylindrical proteases as antimicrobials: identification and development of small molecule activators of ClpP protease.
    Leung E; Datti A; Cossette M; Goodreid J; McCaw SE; Mah M; Nakhamchik A; Ogata K; El Bakkouri M; Cheng YQ; Wodak SJ; Eger BT; Pai EF; Liu J; Gray-Owen S; Batey RA; Houry WA
    Chem Biol; 2011 Sep; 18(9):1167-78. PubMed ID: 21944755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of small-molecule modulators for ClpP protease activity.
    Ye F; Li J; Yang CG
    Mol Biosyst; 2016 Dec; 13(1):23-31. PubMed ID: 27831584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ClpP Protease, a Promising Antimicrobial Target.
    Moreno-Cinos C; Goossens K; Salado IG; Van Der Veken P; De Winter H; Augustyns K
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Validation of DegS As a Target for the Development of Antibiotics with a Novel Mode of Action.
    Bongard J; Schmitz AL; Wolf A; Zischinsky G; Pieren M; Schellhorn B; Bravo-Rodriguez K; Schillinger J; Koch U; Nussbaumer P; Klebl B; Steinmann J; Buer J; Sanchez-Garcia E; Ehrmann M; Kaiser M
    ChemMedChem; 2019 Jun; 14(11):1074-1078. PubMed ID: 30945468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Design and Development of Phosphine Oxides as a Novel Chemotype for Antibiotics that Dysregulate Bacterial ClpP Proteases.
    Lin F; Mabanglo MF; Zhou JL; Binepal G; Barghash MM; Wong KS; Gray-Owen SD; Batey RA; Houry WA
    J Med Chem; 2024 Sep; 67(17):15131-15147. PubMed ID: 39221504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development.
    Jacques S; van der Sloot AM; C Huard C; Coulombe-Huntington J; Tsao S; Tollis S; Bertomeu T; Culp EJ; Pallant D; Cook MA; Bonneil E; Thibault P; Wright GD; Tyers M
    Genetics; 2020 Apr; 214(4):1103-1120. PubMed ID: 32094149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
    Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure at 1.9A of E. coli ClpP with a peptide covalently bound at the active site.
    Szyk A; Maurizi MR
    J Struct Biol; 2006 Oct; 156(1):165-74. PubMed ID: 16682229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics.
    Brötz-Oesterhelt H; Beyer D; Kroll HP; Endermann R; Ladel C; Schroeder W; Hinzen B; Raddatz S; Paulsen H; Henninger K; Bandow JE; Sahl HG; Labischinski H
    Nat Med; 2005 Oct; 11(10):1082-7. PubMed ID: 16200071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus.
    Böttcher T; Sieber SA
    J Am Chem Soc; 2008 Nov; 130(44):14400-1. PubMed ID: 18847196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease.
    Kirstein J; Hoffmann A; Lilie H; Schmidt R; Rübsamen-Waigmann H; Brötz-Oesterhelt H; Mogk A; Turgay K
    EMBO Mol Med; 2009 Apr; 1(1):37-49. PubMed ID: 20049702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of tailored human caseinolytic protease P inhibitors.
    Gronauer TF; Mandl MM; Lakemeyer M; Hackl MW; Meßner M; Korotkov VS; Pachmayr J; Sieber SA
    Chem Commun (Camb); 2018 Aug; 54(70):9833-9836. PubMed ID: 30109319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boronic ester-linked macrocyclic lipopeptides as serine protease inhibitors targeting Escherichia coli type I signal peptidase.
    Szałaj N; Lu L; Benediktsdottir A; Zamaratski E; Cao S; Olanders G; Hedgecock C; Karlén A; Erdélyi M; Hughes D; Mowbray SL; Brandt P
    Eur J Med Chem; 2018 Sep; 157():1346-1360. PubMed ID: 30196059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ClpP Peptidase as a Plausible Target for the Discovery of Novel Antibiotics.
    Bhardwaj S; Roy KK
    Curr Drug Targets; 2024; 25(2):108-120. PubMed ID: 38151841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel class of Plasmodial ClpP protease inhibitors as potential antimalarial agents.
    Mundra S; Thakur V; Bello AM; Rathore S; Asad M; Wei L; Yang J; Chakka SK; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
    Bioorg Med Chem; 2017 Oct; 25(20):5662-5677. PubMed ID: 28917450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored Peptide Phenyl Esters Block ClpXP Proteolysis by an Unusual Breakdown into a Heptamer-Hexamer Assembly.
    Lakemeyer M; Bertosin E; Möller F; Balogh D; Strasser R; Dietz H; Sieber SA
    Angew Chem Int Ed Engl; 2019 May; 58(21):7127-7132. PubMed ID: 30829431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.